ReviewFrontiers in oncology2023

A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma.

Binhao Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.